J Inflamm Dis

Image Credit:J Inflamm Dis

Imported Malaria in Iran: A Policy Brief for Sustaining Elimination Goals

Author(s):
Aida Vafae EslahiAida Vafae EslahiAida Vafae Eslahi ORCID1, Meysam OlfatifarMeysam Olfatifar2, Ioannis AdamopoulosIoannis AdamopoulosIoannis Adamopoulos ORCID3,*, Milad BadriMilad Badri1,**
1Medical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran
2Gastroenterology and Hepatology Diseases Research Center, Qom University of Medical Sciences, Qom, Iran
3Department of Public Health Policy, Sector of Occupational and Environmental Health, School of Public Health, University of West Attica, Athens, Greece
Corresponding Authors:

Journal of Inflammatory Diseases:Vol. 30, issue 1; e168437
Published online:Dec 27, 2025
Article type:Brief Report
Received:Nov 23, 2025
Accepted:Dec 20, 2025
How to Cite:Vafae Eslahi A, Olfatifar M, Adamopoulos I, Badri M. Imported Malaria in Iran: A Policy Brief for Sustaining Elimination Goals.J Inflamm Dis.2025;30(1):e168437.https://doi.org/10.69107/jid-168437.

Abstract

Background:

Iran has made significant progress toward malaria eradication, reaching a pre-elimination stage with a national target of stopping indigenous transmission by 2025. However, imported malaria cases from neighboring endemic countries, particularly Afghanistan and Pakistan, pose a serious threat to sustaining these gains. Recent socio-political instability and increased migration from malaria-endemic regions, especially to urban and peri-urban areas, have heightened the risk of local transmission resurgence.

Objectives:

This policy brief assesses the current challenges posed by imported malaria in Iran and proposes evidence-based strategies to prevent re-establishment of local transmission.

Methods:

Three complementary interventions are recommended: (A) Focused screening and surveillance of high-risk populations; (B) Enhanced border health measures and cross-border collaboration with neighboring endemic countries; and (C) Community-based health education targeting at-risk populations. The key barriers to implementation include financial constraints, limited inter-sectoral coordination, cultural differences, and gaps in data integration.

Conclusions:

Targeted interventions, underpinned by robust health systems and sustained political and financial commitment, are essential to prevent malaria reintroduction and achieve Iran’s 2025 elimination goals.

1. Background and Problem Statement

Malaria, caused by Plasmodium parasites, remains a major global health concern, especially affecting children and pregnant women in tropical and subtropical regions (1). According to the World Health Organization’s (WHO) 2023 World Malaria Report, malaria remains a significant burden, with 249 million cases and 608,000 deaths across 85 endemic countries in 2022 (2). Historically, malaria affected millions in Iran, but the 1951 anti-malaria campaign led to substantial reductions, and recent reports indicate a continuing decline (3, 4). By 2009, Iran had entered the pre-elimination phase, aiming to stop local transmission by 2025 (5). Iran has made remarkable progress in malaria control and is now in the pre-elimination phase, with a national goal to eliminate indigenous transmission by 2025 (6). However, this achievement is fragile. The country now faces a critical challenge: Imported malaria cases from endemic neighboring countries, primarily Afghanistan and Pakistan, threaten to undermine elimination efforts by potentially re-establishing local transmission where competent Anopheles vectors exist.

However, regional instability has influenced malaria dynamics. The recent political change in Afghanistan in 2021, coupled with ongoing economic insecurity, has prompted a significant influx of migrants and refugees into Iran, many originating from malaria-endemic regions within Afghanistan (7, 8). There is a steady flow of Afghan laborers into Iran, particularly young men seeking work, who often have limited access to healthcare and may carry asymptomatic malaria infections (7, 9). Migrants often settle in specific urban and peri-urban areas, creating focal points of potential transmission risk if local vectors are present (9). Qazvin Province, in northern Iran, hosts a significant Afghan refugee population on the city outskirts (10). Qazvin Province illustrates this vulnerability: A 2008 – 2023 retrospective study showed that all malaria cases were imported, predominantly from Afghanistan (9). This pattern reflects a national trend and underscores the need for targeted policies to prevent reintroduction.

2. Materials and Methods

2.1. Study Area and Data Collection

This study was conducted in Iran's Qazvin Province, a 15,821 km² area in the northwest, between 2008 and 2023. During this period, 41 imported malaria cases were identified. Blood samples were collected from patients at provincial Health Centers, and peripheral smears were prepared, stained with Giemsa, and examined by light microscopy for parasite detection. All cases were confirmed by laboratory diagnosis, with no reported fatalities. For each confirmed case, a comprehensive questionnaire was completed, documenting demographic and clinical details such as age, gender, occupation, nationality, parasite species, and the method of case detection (active or passive).

3. Policy Options and Implementation Strategies

We propose three complementary policy alternatives to address the challenge posed by imported malaria:

3.1. Option 1: Targeted Surveillance and Screening of High-Risk Populations

This entails the systematic identification and assessment of individuals exhibiting the highest susceptibility to imported malaria.

Activities: Implement obligatory screening protocols for migrants and returning travelers from endemic regions at designated border crossing points (11). Establish proactive case detection initiatives and community-based screening efforts in urban locales characterized by significant concentrations of Afghan laborers (12).

Advantages: Facilitates early detection and treatment, thereby averting severe disease progression and potential local outbreaks. Allocates limited resources efficiently to focus on the demographic contributing to the issue (13).

Disadvantages: Necessitates considerable investment in rapid diagnostic tests (RDTs) and trained healthcare personnel. Potential cultural barriers may hinder effective implementation (14, 15).

Acceptability: High, as it is directly aligned with the national elimination objective and provides a pragmatic, focused methodology (16, 17).

The key barriers and recommended implementation strategies are summarized in Table 1.

Table 1. Key Barriers to Preventing Imported Malaria and Recommended Implementation Strategies
BarrierDescriptionImplementation Strategies
Financial constraintsImplementing surveillance, screening, and cross-border initiatives requires substantial investment.Mobilize resources through the national health budget, and apply for grants from global health initiatives (e.g., the global fund). Pilot programs in high-risk provinces can demonstrate cost-effectiveness.
Inter-sectoral coordinationEffective implementation requires coordination between the Ministry of health, border security, foreign affairs, and labor.Establish a national malaria elimination taskforce with representation from all key ministries to ensure coordinated policy and action.
Cultural barriersEffective communication with Afghan populations is hindered by cultural differences.Employ cultural mediators.
Data management and integrationCurrent health information systems may not be optimized to track imported cases and link them to migrant health services.Strengthen the health management information system to include variables on nationality, travel history, and cross-border movement for malaria cases.

3.2. Option 2: Enhanced Border Health Initiatives and Cross-Border Collaboration

This alternative emphasizes inter-country cooperation aimed at mitigating the influx of infected individuals while synchronizing control efforts.

Activities: Augment health assessments and health education initiatives at formal border checkpoints. Establish collaborative surveillance, data-sharing agreements, and coordinated response plans in conjunction with the health authorities of Afghanistan and Pakistan (18, 19).

Advantages: Addresses the issue at its origin. Promotes regional collaboration, which is critical for sustained elimination efforts in the area (20).

Disadvantages: Logistically and politically intricate, necessitating high-level diplomatic engagement and ongoing commitment from all involved parties (21).

Acceptability: Moderate to high within the health sector; however, successful implementation is contingent upon broader foreign policy frameworks and bilateral relations (21, 22).

3.3. Option 3: Community-Based Health Education and Engagement Within At-Risk Demographics

This seeks to enhance knowledge and promote protective behaviors among migrant communities.

Activities: Develop and disseminate culturally tailored educational resources regarding malaria symptoms, prevention strategies, and the imperative of seeking timely treatment (23). Train and deploy community health workers (CHWs) sourced from within these populations (24).

Advantages: Empowers communities, fosters trust in the healthcare system, and has the potential to enhance case detection and reporting. Complements screening initiatives effectively (25).

Disadvantages: Requires time to cultivate trust and establish effective communication channels. Outcomes may prove challenging to quantify in the short term (26, 27).

Acceptability: High, as it represents a foundational public health practice that can be integrated with other primary healthcare services for migrants (28, 29).

4. Policy Recommendations

Substantial progress toward malaria elimination has been made in Iran. However, it faces a serious challenge from imported cases, particularly from neighboring endemic countries such as Afghanistan and Pakistan. To sustain these gains and achieve the 2025 elimination target, the country must implement targeted interventions, including:

Systematic screening programs should be implemented for returning travelers and migrants from endemic regions at official border crossings. The use of RDTs should be expanded for timely case detection, especially among Afghan laborers residing in peri-urban areas. Collaboration agreements should be established or enhanced with the health ministries of Afghanistan and Pakistan for data sharing and coordinated outbreak response planning. Capacity for health monitoring at borders should be increased, and education should be provided to crossing travelers. Educational content (e.g., brochures, videos) should be developed and distributed in languages common among migrant communities (such as Dari and Pashto) about malaria symptoms and the importance of prompt treatment. The CHWs should be recruited, trained, and deployed from within these communities to increase effectiveness and build trust. The Health Management Information System (HMIS) should be upgraded to effectively track imported cases by including variables such as nationality, travel history, and linkage to migrant health services. Data from different sectors (health, border security) should be integrated for better analysis of disease importation patterns. Dedicated and sustained funding should be allocated within the national health budget for malaria elimination activities. Technical and financial assistance should be secured by applying for grants from international bodies such as the Global Fund to Fight AIDS, Tuberculosis and Malaria. These recommendations align with the barriers and strategies highlighted in Table 1.

5. Discussion

Iran has successfully interrupted local malaria transmission, yet the persistent influx of imported cases, primarily among young Afghan male laborers, presents a critical vulnerability. To safeguard elimination achievements and meet the 2025 target, Iran must shift from broad national measures to targeted, practical interventions. These include implementing mandatory screening at borders and in-migrant communities using RDTs, enhancing cross-border collaboration for joint surveillance and outbreak response with Afghanistan and Pakistan, and scaling up culturally adapted community health education delivered by trained CHWs. The sustained success of these measures depends on strong inter-sectoral coordination, dedicated national funding, and support from international partners. With committed political and financial backing, Iran can prevent the re-establishment of malaria and achieve its elimination goal.

Footnotes

References

  • 1.
    Oladipo HJ, Tajudeen YA, Oladunjoye IO, Yusuff SI, Yusuf RO, Oluwaseyi EM, et al. Increasing challenges of malaria control in sub-Saharan Africa: Priorities for public health research and policymakers. Ann Med Surg. 2022;81:104366. [PubMed ID: 36046715]. [PubMed Central ID: PMC9421173]. https://doi.org/10.1016/j.amsu.2022.104366.
  • 2.
    Venkatesan P. The 2023 WHO World Malaria Report. Lancet Microbe. 2024;5(3). e214. [PubMed ID: 38309283]. https://doi.org/10.1016/S2666-5247(24)00016-8.
  • 3.
    Khalili MB, Anvari-Tafti MH, Sadeh M. Epidemiological Pattern of Malarial Disease in the Province of Yazd, Iran (Since 1986-2006). World J Med Sci. 2009;4(1):41-5.
  • 4.
    Manouchehri AV, Zaim M, Emadi AM. A Review of Malaria in Iran, 1975-90. J Am Mosq Control Assoc. 1992;8(4):381-5. [PubMed ID: 1474383].
  • 5.
    Hemami MR, Sari AA, Raeisi A, Vatandoost H, Majdzadeh R. Malaria Elimination in Iran, Importance and Challenges. Int J Prev Med. 2013;4(1):88-94. [PubMed ID: 23413116]. [PubMed Central ID: PMC3570917].
  • 6.
    Saied AA, Salehi M, Shafaati M. Malaria Elimination Programme in Iran: Challenges and Opportunities. J Travel Med. 2024;31(8). [PubMed ID: 39096507]. https://doi.org/10.1093/jtm/taae101.
  • 7.
    Pourhossein B, Irani AD, Mostafavi E. Major Infectious Diseases Affecting The Afghan Immigrant Population of Iran: A Systematic Review and Meta-Analysis. Epidemiol Health. 2015;37. e2015002. [PubMed ID: 25666236]. [PubMed Central ID: PMC4371390]. https://doi.org/10.4178/epih/e2015002.
  • 8.
    Koohsar F, Faridnia R, Jorjani O, Hojjati MT, Yadagiri G, Noshak G, et al. The resurgence of malaria in Northern Iran in 2023: A wake-up call. BMC Infect Dis. 2025;25(1):921. [PubMed ID: 40665230]. [PubMed Central ID: PMC12265256]. https://doi.org/10.1186/s12879-025-11266-x.
  • 9.
    Badri M, Modarresnia L, Asghari A, Olfatifar M, Sgroi G, Najafpour B, et al. Imported malaria in Qazvin Province, Iran: A retrospective study from 2008 to 2023. Arch Razi Inst. 2025. https://doi.org/10.22092/ari.2025.367991.3461.
  • 10.
    Gholamzadeh Khoei S, Sadeghi H, Bakht M, Rahimi S, Mirshahabi H, Gheibi N. Serosurvey of Hepatitis-B Surface Antigen in Afghan Refugees; the First Report from Qazvin, Iran. J Res Appl Basic Med Sci. 2020;6(3):194-8. eng. https://doi.org/10.13183/rabms.6.3.194.
  • 11.
    Sturrock HJW, Roberts KW, Wegbreit J, Ohrt C, Gosling RD. Tackling imported malaria: an elimination endgame. Am J Trop Med Hyg. 2015;93(1):139-44. [PubMed ID: 26013369]. [PubMed Central ID: PMC4497886]. https://doi.org/10.4269/ajtmh.14-0256.
  • 12.
    Howard N. Malaria control for Afghans in Pakistan and Afghanistan (1990-2005): a mixed-methods assessment considering effectiveness, efficiency, equity, and humanity [Thesis]. London, UK: University of London; 2017.
  • 13.
    Landier J, Parker DM, Thu AM, Carrara VI, Lwin KM, Bonnington CA, et al. The role of early detection and treatment in malaria elimination. Malar J. 2016;15:363. [PubMed ID: 27421656]. [PubMed Central ID: PMC4946177]. https://doi.org/10.1186/s12936-016-1399-y.
  • 14.
    Nsengimana A, Isimbi J, Uwizeyimana T, Biracyaza E, Hategekimana JC, Uwambajimana C, et al. Malaria rapid diagnostic tests in community pharmacies in Rwanda: availability, knowledge of community pharmacists, advantages, and disadvantages of licensing their use. Glob Health Res Policy. 2023;8(1):40. [PubMed ID: 37700374]. [PubMed Central ID: PMC10496312]. https://doi.org/10.1186/s41256-023-00324-z.
  • 15.
    Chandler CI, Whitty CJ, Ansah EK. How can malaria rapid diagnostic tests achieve their potential? A qualitative study of a trial at health facilities in Ghana. Malar J. 2010;9(1):95. [PubMed ID: 20398262]. [PubMed Central ID: PMC2859355]. https://doi.org/10.1186/1475-2875-9-95.
  • 16.
    Onyango L, Ouedraogo-Ametchie G, Ozodiegwu I, Galatas B, Gerardin J. Subnational tailoring of malaria interventions for strategic planning and prioritization: Experience and perspectives of five malaria programs. PLOS Glob Public Health. 2025;5(5). e0003811. [PubMed ID: 40435171]. [PubMed Central ID: PMC12118815]. https://doi.org/10.1371/journal.pgph.0003811.
  • 17.
    Parkhurst J, Ghilardi L, Webster J, Hoyt J, Hill J, Lynch CA. Understanding evidence use from a programmatic perspective: conceptual development and empirical insights from national malaria control programmes. Evid Polic. 2021;17(3):447-66. https://doi.org/10.1332/174426420x15967828803210.
  • 18.
    Fambirai T, Chimbari MJ, Ndarukwa P. Global Cross-Border Malaria Control Collaborative Initiatives: A Scoping Review. Int J Environ Res Public Health. 2022;19(19). [PubMed ID: 36231519]. [PubMed Central ID: PMC9566216]. https://doi.org/10.3390/ijerph191912216.
  • 19.
    World Health Organization. Mekong Malaria Elimination (MME) Programme Partners’ Forum, March 2018. Geneva, Switzerland: World Health Organization; 2018. Available from: https://www.who.int/publications/i/item/WHO-CDS-GMP-MME-2019.01.
  • 20.
    Newby G, Bennett A, Larson E, Cotter C, Shretta R, Phillips AA, et al. The path to eradication: a progress report on the malaria-eliminating countries. Lancet. 2016;387(10029):1775-84. [PubMed ID: 27116283]. https://doi.org/10.1016/S0140-6736(16)00230-0.
  • 21.
    Kevany S, Sahak O, Workneh NG, Saeedzai SA. Global health diplomacy investments in Afghanistan: adaptations and outcomes of global fund malaria programs. Med Confl Surviv. 2014;30(1):37-55. [PubMed ID: 24684022]. https://doi.org/10.1080/13623699.2014.874187.
  • 22.
    Jezek T, Bamodu OA. A cross-country comparison of malaria policy as a premise for contextualized appropriation of foreign aid in global health. Health Res Policy Syst. 2021;19(1):93. [PubMed ID: 34127020]. [PubMed Central ID: PMC8201720]. https://doi.org/10.1186/s12961-021-00700-6.
  • 23.
    Firdaus MH, Wan Puteh SE, Sutan R, Abdul Manaf MR. Effectiveness of family health education in malaria elimination programmes: a scoping review. Malar J. 2025;24(1):144. [PubMed ID: 40336085]. [PubMed Central ID: PMC12056992]. https://doi.org/10.1186/s12936-025-05371-0.
  • 24.
    Mugisha Emmanuel K. Enhancing Malaria and Anemia Management through Community Engagement and Health Education: Assessing the Impact of Local Health Programs on Prevention, Awareness, and Treatment-Seeking Behavior. EEJSAR Exper J Sci Appl Res. 2024;6(3):38-42.
  • 25.
    Obeagu EI, Obeagu GU, Iduh MU. Behavioral health interventions in malaria control: Efficacy and implementation. Medicine. 2025;104(31). e43762. [PubMed ID: 40760569]. [PubMed Central ID: PMC12324027]. https://doi.org/10.1097/MD.0000000000043762.
  • 26.
    Awasthi KR, Jancey J, Clements ACA, Rai R, Leavy JE. Community engagement approaches for malaria prevention, control and elimination: a scoping review. BMJ Open. 2024;14(2). e081982. [PubMed ID: 38365295]. [PubMed Central ID: PMC10875526]. https://doi.org/10.1136/bmjopen-2023-081982.
  • 27.
    WHO Expert Committee. WHO Expert Committee on Malaria: : Twentieth Report. Geneva, Switzerland: World Health Organization; 2000. Available from: https://iris.who.int/server/api/core/bitstreams/48726ba1-1a02-42a7-91a4-21def9d413d2/content.
  • 28.
    World Health Organization. Population mobility and malaria,. Geneva, Switzerland: World Health Organization; 2017. Available from: https://iris.who.int/items/fafb0720-b0a0-4188-bdf6-dc8946852fae.
  • 29.
    Inkochasan M, Gopinath D, Vicario E, Lee A, Duigan P. Access to health care for migrants in the Greater Mekong Subregion: policies and legal frameworks and their impact on malaria control in the context of malaria elimination. WHO South East Asia J Public Health. 2019;8(1):26-34. [PubMed ID: 30950427]. https://doi.org/10.4103/2224-3151.255346.

Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Purchasing Reprints

  • Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here (   https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.
Search Relations

Author(s):

Related Articles